Updates Select Full Year Fiscal 2023 Financial GuidanceWEST LAFAYETTE, Ind., May 11, 2023 Inotiv, Inc. , a leading contract research organization specializing in nonclinical and analytical drug. | May 11, 2023
WEST LAFAYETTE, Ind., Feb. 13, 2023 (GLOBE NEWSWIRE) Inotiv, Inc. (Nasdaq: NOTV) (the "Company", "We", "Our" or "Inotiv"), a leading contract research organization specializing in nonclinical and analytical
Operator: Hello, and welcome to Inotiv Inc. s First Quarter Fiscal 2023 Financial Results Conference Call and Webcast. A question-and-answer session will follow the formal presentation.
/PRNewswire/ The Global Genetic Toxicology Testing Market size is expected to reach $2.4 billion by 2028, rising at a market growth of 13.2% CAGR during the.
10.08.2022 - Increases Select Fiscal Year 2022 Financial GuidanceWEST LAFAYETTE, Ind., Aug. 10, 2022 (GLOBE NEWSWIRE) - Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical .